Phosphorescent Iridium Hydrazinonicotinic Acid (HYNIC) Complexes That Bind to Prostate Specific Membrane Antigen: Potential Photodynamic Therapy of Prostate Cancer
Chemistry – A European Journal · 02.07.2026 · 32 (25)
DOI: 10.1002/chem.71011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 17.04.2026. Verfasst von La'El Kimchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Iridium, Prostatic Neoplasms, Coordination Complexes, Photosensitizing Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, National Health and Medical Research Council, Australian Cancer Research Foundation.
Abstract (Originalsprache)
Phosphorescent metal complexes have the potential to be used for photodynamic detection of tumor margins in surgery and photodynamic therapy (PDT). In this work, iridium(III) complexes are prepared with two cyclometalating ligands, either phenylpyridine (ppy) or phenylisoquinoline (piq), and one 6‐hydrazinonicotinic acid (HYNIC) ancillary ligand to give [Ir(ppy) 2 (HYNIC)] + and [Ir(piq) 2 (HYNIC)] + . The extended conjugation in [Ir(piq) 2 (HYNIC)] + results in a significant redshift in the absorption and emission properties. Both [Ir(ppy) 2 (HYNIC)] + and [Ir(piq) 2 (HYNIC)] + generate singlet oxygen upon irradiation with light in the presence of oxygen. Irradiation of [Ir(piq) 2 (HYNIC)] + ( λ exc = 420 nm) results in the production of hydroxyl and superoxide radicals. The carboxylic acid functional group in HYNIC has been used to attach a lysine‐ureido‐glutamatic acid pharmacophore that selectively binds to prostate specific membrane antigen (PSMA) to give HYNIC–PSMA. PSMA is an enzyme that is overexpressed in prostate cancer. HYNIC–PSMA was used to prepare [Ir(ppy) 2 (HYNIC–PSMA)] + and [Ir(piq) 2 (HYNIC–PSMA)] + . Both complexes bind to cells that overexpress the PSMA enzyme. [Ir(piq) 2 (HYNIC‐PSMA)] + is nontoxic to cells in the dark, but irradiation with visible light results in a dose‐dependent cytotoxicity. These complexes have the potential to be of use to identify tumor margins, to guide robot‐assisted surgical resection of tumors, as well as for molecularly targeted PDT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria, Australia.
- School of Chemistry, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Paul S Donnelly
Förderung
- Australian Research Council
- National Health and Medical Research Council
- Australian Cancer Research Foundation
Zitieren
APA
Kimchi, L., McGowan, E. R., Morgan, K. A., White, J. M., Smith, T. A., Rudd, S. E., & Donnelly, P. S. (2026). Phosphorescent Iridium Hydrazinonicotinic Acid (HYNIC) Complexes That Bind to Prostate Specific Membrane Antigen: Potential Photodynamic Therapy of Prostate Cancer. Chemistry – A European Journal, 32(25). https://doi.org/10.1002/chem.71011
Vancouver
Kimchi L, McGowan ER, Morgan KA, White JM, Smith TA, Rudd SE, et al. Phosphorescent Iridium Hydrazinonicotinic Acid (HYNIC) Complexes That Bind to Prostate Specific Membrane Antigen: Potential Photodynamic Therapy of Prostate Cancer. Chemistry – A European Journal. 2026;32(25). doi:10.1002/chem.71011
BibTeX
@article{Kimchi2026,
author = {Kimchi, La'El and McGowan, Emily R and Morgan, Katherine A and White, Jonathan M and Smith, Trevor A and Rudd, Stacey E and Donnelly, Paul S},
title = {Phosphorescent Iridium Hydrazinonicotinic Acid (HYNIC) Complexes That Bind to Prostate Specific Membrane Antigen: Potential Photodynamic Therapy of Prostate Cancer},
journal = {Chemistry – A European Journal},
year = {2026},
volume = {32},
number = {25},
doi = {10.1002/chem.71011}
}
EUVIMED